Carbinoxamine maleate 0.8 MG/ML Oral Solution [Carbzah] — RxCUI 2730039
RxNorm drug concept · Semantic branded drug
RxCUI 2730039
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2730039
Official nameCarbinoxamine maleate 0.8 MG/ML Oral Solution [Carbzah]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asCarbzah 4 MG per 5 ML Oral Solution; CARBZAH 4 MG in 5 mL Oral Solution
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)95 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Carbinoxamine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Carbinoxamine is an antihistamine that relieves allergy symptoms — things like a runny nose, sneezing, itchy or watery eyes, and skin reactions like hives or swelling. It also work...
- What exactly does carbinoxamine help with?
- Yes — drowsiness is one of the most common side effects, and it can be significant. Carbinoxamine is an older-style antihistamine that crosses into the brain, so it tends to be mor...
- If you've been prescribed Karbinal ER or Carbinoxamine Maleate Extended-Release Oral Suspension, always shake the bottle well before measuring each dose. Use the measuring device p...
🕸️ Concept Web — How Carbinoxamine maleate 0.8 MG/ML Oral Solution [C... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Carbinoxamine maleate 0.8 MG/ML Oral Solution [Carbzah]
RxCUI 2730039 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Carbinoxamine
20220IN -
Carbinoxamine maleate
91066PIN
-
Carbinoxamine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Carbzah
2730033BN
-
Carbzah
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Carbinoxamine Oral Solution
371275SCDF -
Carbinoxamine maleate Oral Solution
2647159SCDFP -
Carbinoxamine Oral Liquid Product
1160574SCDG -
Carbinoxamine Oral Product
1160575SCDG -
Carbinoxamine maleate Oral Liquid Product
2662317SCDGP -
Carbinoxamine maleate Oral Product
2659504SCDGP -
Carbinoxamine Oral Solution [Carbzah]
2730037SBDF -
Carbinoxamine maleate Oral Solution [Carbzah]
2730038SBDFP - +5 more in this family
-
Carbinoxamine Oral Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Carbinoxamine maleate 0.8 MG/ML Oral Solution
1010696SCD -
Carbinoxamine maleate 0.8 MG/ML
1010695SCDC -
Carbinoxamine maleate 0.8 MG/ML [Carbzah]
2730034SBDC
-
Carbinoxamine maleate 0.8 MG/ML Oral Solution
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Carbinoxamine maleate 0.8 MG/ML Oral Solution
SCD · 1010696 -
Carbinoxamine maleate 0.8 MG/ML
SCDC · 1010695 -
Carbinoxamine Oral Solution
SCDF · 371275 -
Carbinoxamine maleate Oral Solution
SCDFP · 2647159 -
Carbinoxamine Oral Liquid Product
SCDG · 1160574 -
Carbinoxamine Oral Product
SCDG · 1160575 -
Carbinoxamine maleate Oral Liquid Product
SCDGP · 2662317 -
Carbinoxamine maleate Oral Product
SCDGP · 2659504
Brand-Name Concepts
-
Carbinoxamine maleate 0.8 MG/ML [Carbzah]
SBDC · 2730034 -
Carbinoxamine Oral Solution [Carbzah]
SBDF · 2730037 -
Carbinoxamine maleate Oral Solution [Carbzah]
SBDFP · 2730038 -
Carbzah Oral Liquid Product
SBDG · 2730036 -
Carbzah Oral Product
SBDG · 2730035 -
Carbzah
BN · 2730033
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2730039 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 71085-0080-07 | 473 mL in 1 BOTTLE, PLASTIC (71085-080-07) | CARBZAH | IPG Pharmaceuticals, inc. | 2025-06-01 |
Observed labelers:
IPG Pharmaceuticals, inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.